Guardant Health, Inc. — Director's Dealing 2021

Feb 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Guardant Health, Inc. (GH)
CIK: 0001576280
Period of Report: 2021-02-10

Reporting Person: Talasaz AmirAli (Director, Chairman, President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-10	COMMON STOCK	S	4069	$156.1101	Disposed	1981908	Direct
2021-02-10	COMMON STOCK	S	4579	$156.7748	Disposed	1977329	Direct
2021-02-10	COMMON STOCK	S	709	$158.1274	Disposed	1976620	Direct
2021-02-10	COMMON STOCK	S	5007	$158.9699	Disposed	1971613	Direct
2021-02-10	COMMON STOCK	S	4583	$160.0813	Disposed	1967030	Direct
2021-02-10	COMMON STOCK	S	4594	$161.0573	Disposed	1962436	Direct
2021-02-10	COMMON STOCK	S	27471	$162.1032	Disposed	1934965	Direct
2021-02-10	COMMON STOCK	S	2292	$162.876	Disposed	1932673	Direct
2021-02-10	COMMON STOCK	S	5000	$163.9825	Disposed	1927673	Direct
2021-02-10	COMMON STOCK	S	492	$156.1097	Disposed	509139	Indirect
2021-02-10	COMMON STOCK	S	701	$156.7961	Disposed	508438	Indirect
2021-02-10	COMMON STOCK	S	141	$158.08	Disposed	508297	Indirect
2021-02-10	COMMON STOCK	S	759	$158.9812	Disposed	507538	Indirect
2021-02-10	COMMON STOCK	S	621	$160.0729	Disposed	506917	Indirect
2021-02-10	COMMON STOCK	S	653	$161.0166	Disposed	506264	Indirect
2021-02-10	COMMON STOCK	S	4497	$162.1148	Disposed	501767	Indirect
2021-02-10	COMMON STOCK	S	496	$163.0262	Disposed	501271	Indirect
2021-02-10	COMMON STOCK	S	329	$163.9427	Disposed	500942	Indirect
2021-02-11	COMMON STOCK	S	2308	$162.651	Disposed	1925365	Direct
2021-02-11	COMMON STOCK	S	1372	$164.1015	Disposed	1923993	Direct
2021-02-11	COMMON STOCK	S	48728	$165.5456	Disposed	1875265	Direct
2021-02-11	COMMON STOCK	S	44676	$166.5076	Disposed	1830589	Direct
2021-02-11	COMMON STOCK	S	49899	$167.4686	Disposed	1780690	Direct
2021-02-11	COMMON STOCK	S	50245	$168.3681	Disposed	1730445	Direct
2021-02-11	COMMON STOCK	S	5023	$169.0309	Disposed	1725422	Direct
2021-02-11	COMMON STOCK	S	144	$162.8146	Disposed	500798	Indirect
2021-02-11	COMMON STOCK	S	204	$164.1018	Disposed	500594	Indirect
2021-02-11	COMMON STOCK	S	7116	$165.5456	Disposed	493478	Indirect
2021-02-11	COMMON STOCK	S	6764	$166.5267	Disposed	486714	Indirect
2021-02-11	COMMON STOCK	S	9301	$167.4725	Disposed	477413	Indirect

Footnotes

F1: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.44 to $156.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: The amount of shares beneficially owned reflects the addition of 345 shares that were previously incorrectly reported as sold on Form 4s filed on February 3, 2021 and February 5, 2021.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.44 to $157.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.44 to $158.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.53 to $159.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.53 to $160.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.53 to $161.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.59 to $162.565, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.59 to $163.565, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.59 to $164.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.40 to $163.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.61 to $164.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.72 to $165.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.7275 to $166.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.74 to $167.735, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.74 to $168.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.74 to $169.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.